Annual Accounts Payable
$4.63 M
+$2.56 M+123.12%
December 31, 2023
Summary
- As of February 8, 2025, NRXP annual accounts payable is $4.63 million, with the most recent change of +$2.56 million (+123.12%) on December 31, 2023.
- During the last 3 years, NRXP annual accounts payable has risen by +$1.48 million (+46.91%).
- NRXP annual accounts payable is now at all-time high.
Performance
NRXP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.87 M
-$149.00 K-2.97%
September 30, 2024
Summary
- As of February 8, 2025, NRXP quarterly accounts payable is $4.87 million, with the most recent change of -$149.00 thousand (-2.97%) on September 30, 2024.
- Over the past year, NRXP quarterly accounts payable has dropped by -$1.40 million (-22.33%).
- NRXP quarterly accounts payable is now -22.37% below its all-time high of $6.27 million, reached on June 30, 2021.
Performance
NRXP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NRXP Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +123.1% | -22.3% |
| 3 y3 years | +46.9% | +124.5% |
| 5 y5 years | +46.9% | - |
NRXP Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +123.1% | -22.3% | +134.4% |
| 5 y | 5-year | at high | +123.1% | -22.4% | +134.4% |
| alltime | all time | at high | +123.1% | -22.4% | +134.4% |
NRx Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.87 M(-3.0%) |
| Jun 2024 | - | $5.01 M(-20.0%) |
| Mar 2024 | - | $6.26 M(+35.3%) |
| Dec 2023 | $4.63 M(+123.1%) | $4.63 M(+27.6%) |
| Sep 2023 | - | $3.63 M(+64.7%) |
| Jun 2023 | - | $2.21 M(-41.6%) |
| Mar 2023 | - | $3.78 M(+81.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $2.08 M(-43.7%) | $2.08 M(-4.2%) |
| Sep 2022 | - | $2.17 M(-29.6%) |
| Jun 2022 | - | $3.08 M(-28.6%) |
| Mar 2022 | - | $4.31 M(+16.9%) |
| Dec 2021 | $3.69 M(+16.9%) | $3.69 M(-33.7%) |
| Sep 2021 | - | $5.56 M(-11.3%) |
| Jun 2021 | - | $6.27 M(+98.8%) |
| Dec 2020 | $3.15 M | $3.15 M |
FAQ
- What is NRx Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual accounts payable year-on-year change?
- What is NRx Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly accounts payable year-on-year change?
What is NRx Pharmaceuticals annual accounts payable?
The current annual accounts payable of NRXP is $4.63 M
What is the all time high annual accounts payable for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual accounts payable is $4.63 M
What is NRx Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, NRXP annual accounts payable has changed by +$2.56 M (+123.12%)
What is NRx Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of NRXP is $4.87 M
What is the all time high quarterly accounts payable for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly accounts payable is $6.27 M
What is NRx Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, NRXP quarterly accounts payable has changed by -$1.40 M (-22.33%)